Journal article
The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
Frontiers in immunology, Vol.10, pp.2331-2331
10/04/2019
DOI: 10.3389/fimmu.2019.02331
PMCID: PMC6787172
PMID: 31636640
Abstract
Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by autoantibodies targeting cellular adhesion molecules. While IgE autoantibodies are occasionally reported in other autoimmune blistering diseases, BP is unique in that most BP patients develop an IgE autoantibody response. It is not known why BP patients develop self-reactive IgE and the precise role of IgE in BP pathogenesis is not fully understood. However, clinical evidence suggests an association between elevated IgE antibodies and eosinophilia in BP patients. Since eosinophils are multipotent effector cells, capable cytotoxicity and immune modulation, the putative interaction between IgE and eosinophils is a primary focus in current studies aimed at understanding the key components of disease pathogenesis. In this review, we provide an overview of BP pathogenesis, highlighting clinical and experimental evidence supporting central roles for IgE and eosinophils as independent mediators of disease and via their interaction. Additionally, therapeutics targeting IgE, the Th2 axis, or eosinophils are also discussed.
Details
- Title: Subtitle
- The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
- Creators
- Kelly N. Messingham - , , , ,Tyler P. Crowe - University of IowaJanet A. Fairley - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Frontiers in immunology, Vol.10, pp.2331-2331
- DOI
- 10.3389/fimmu.2019.02331
- PMID
- 31636640
- PMCID
- PMC6787172
- NLM abbreviation
- Front Immunol
- ISSN
- 1664-3224
- eISSN
- 1664-3224
- Publisher
- Frontiers Media S.A
- Language
- English
- Date published
- 10/04/2019
- Academic Unit
- Dermatology
- Record Identifier
- 9984296308102771
Metrics
28 Record Views